Kinectrics
is pleased to announce that the company has become a newly ratified member of
the new Canadian Nuclear Isotope Council (CNIC).
The CNIC is a coalition
in science, healthcare and nuclear sector organization to ensure Canada remain
a World Leader in the production of life saving Isotopes, by bringing awareness
and supporting long-term policies at the domestic and international level, that
will save countless lives and support health care innovation for decades to
come.
As the leading service provider to the CANDU fleet,
Kinectrics has been involved in every aspect of CANDU technology over the
years. As the fleet now moves to the production of medical Isotopes for
cancer therapy, Kinectrics is poised to be at the forefront of this next
evolution - producing lifesaving Isotopes. “Kinectrics is thrilled to
have joined the Canadian Nuclear Isotope Council (CNIC). Our interests go far
beyond what happens in the reactor, with a vision to ultimately refine and
produce medical grade Isotopes in our Bruce County facilities with our
partners. This is an extremely exciting time for the CANDU Industry and
Kinectrics is proud to be part of this initiative, which has the potential of
positively changing the lives of many of those battling cancer.” – David
Harris, CEO
Since
1940, Canada has been a global leader in producing isotopes used to save lives
through medical imaging, cancer therapy, sterilization, and diagnostic
development. The demand for a reliable
supply of these critical isotopes continues to grow with advancements in health
care and as jurisdictions seek to secure fair access to diagnostics and
treatments for patients as sterilization is recognized as critical to clean
hospitals and infection control.
Canada
has long been a historical leader in isotope production and has fostered an
innovative industry that has saved millions of lives around the world. The
world has come to depend on a commitment that every Canadian government has
supported for over 50 years.
The Government of
Canada and the bipartisan Standing Committee on Natural Resources recently
declared Ontario’s nuclear innovations a success story, recognizing the
critical role that radioisotopes play in the global community, and stated its
intention to work with industry, healthcare community, and
provincial/territorial governments to ensure that the Canadian supply of
radioisotopes is brought to the next level.
Isotopes are an
important part of Canada’s innovation agenda, and beyond medicine, the nuclear
sector contributes to a wide range of other scientific and economic activities,
including energy, human health and safety, material testing, food safety, and
even space exploration
Today, more than 40 per cent of the world’s single-use medical devices,
such as syringes, gloves, implants and surgical instruments, are irradiated and
sterilized with Cobalt-60.
The council hopes to help maintain Canada’s role as a leader in this
field by encouraging innovation and investment in the radioisotope industry by
industries and government.
To
learn more about the CNIC visit www.CanadianIsotopes.ca.